Huibing Li

505 total citations
18 papers, 388 citations indexed

About

Huibing Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Huibing Li has authored 18 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Huibing Li's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Huibing Li is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Huibing Li collaborates with scholars based in China. Huibing Li's co-authors include Song Li, Che Wang, Zhijun Li, Lili Tian, Dejing Shang, Fengming Lan, Qinghong Sun, Xiaodan Zhang, Xiao Yue and Bisheng Zhou and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochimie.

In The Last Decade

Huibing Li

16 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huibing Li China 9 295 193 103 35 34 18 388
Bo Zhan China 11 210 0.7× 143 0.7× 59 0.6× 36 1.0× 20 0.6× 17 349
Sarah Line Skovbakke Denmark 12 231 0.8× 54 0.3× 64 0.6× 161 4.6× 27 0.8× 18 327
Zenghui Li China 13 320 1.1× 96 0.5× 15 0.1× 22 0.6× 34 1.0× 29 437
Ivan V. Chernikov Russia 10 420 1.4× 106 0.5× 8 0.1× 49 1.4× 34 1.0× 24 487
Yunping Lu China 10 266 0.9× 64 0.3× 11 0.1× 46 1.3× 107 3.1× 22 406
Xidong Gu China 9 232 0.8× 206 1.1× 13 0.1× 12 0.3× 57 1.7× 20 322
Jonathan Kearsey France 7 280 0.9× 20 0.1× 49 0.5× 33 0.9× 49 1.4× 7 345
Becky Hood United States 8 147 0.5× 97 0.5× 6 0.1× 49 1.4× 45 1.3× 10 271
Bård Indrevoll Norway 10 213 0.7× 17 0.1× 84 0.8× 62 1.8× 104 3.1× 17 470

Countries citing papers authored by Huibing Li

Since Specialization
Citations

This map shows the geographic impact of Huibing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibing Li more than expected).

Fields of papers citing papers by Huibing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huibing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibing Li. The network helps show where Huibing Li may publish in the future.

Co-authorship network of co-authors of Huibing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huibing Li. A scholar is included among the top collaborators of Huibing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huibing Li. Huibing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Huibing, et al.. (2025). LOX+ iCAFs in HNSCC have the potential to predict prognosis and immunotherapy responses revealed by single cell RNA sequencing analysis. Scientific Reports. 15(1). 7028–7028. 2 indexed citations
2.
Ding, Rui, Xiaohong Qin, Yanhua Wang, et al.. (2024). Multi-targeted olink proteomics analyses of cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Proteome Science. 22(1). 11–11. 2 indexed citations
4.
Xie, Teng, et al.. (2024). Metabolome and transcriptome integration reveals cerebral cortical metabolic profiles in rats with subarachnoid hemorrhage. Frontiers in Aging Neuroscience. 16. 1424312–1424312.
5.
Li, Huibing, et al.. (2023). Knockdown of circ_CLIP2 regulates the proliferation, metastasis and apoptosis of glioma cells through miR-641/EPHA3/STAT3 axis. Journal of Neurogenetics. 37(3). 93–102. 2 indexed citations
6.
Li, Huibing, et al.. (2022). ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression. Human Cell. 35(5). 1591–1601. 11 indexed citations
7.
Li, Huibing, et al.. (2022). NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1. Disease Markers. 2022. 1–12. 5 indexed citations
8.
Li, Huibing, et al.. (2022). Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycle‑associated protein 3. International Journal of Molecular Medicine. 50(3). 8 indexed citations
9.
Yang, Huihui, et al.. (2022). Compression Elastography and Shear Wave Ultrasound Elastography for Measurement of Brain Elasticity in Full‐Term and Premature Neonates. Journal of Ultrasound in Medicine. 42(1). 221–231. 5 indexed citations
10.
Lan, Fengming, Xiaodan Zhang, Huibing Li, Xiao Yue, & Qinghong Sun. (2021). Serum exosomal lncRNA XIST is a potential non‐invasive biomarker to diagnose recurrence of triple‐negative breast cancer. Journal of Cellular and Molecular Medicine. 25(16). 7602–7607. 54 indexed citations
11.
Zhang, Yang, et al.. (2020). <p>Circ_0057553/miR-515-5p Regulates Prostate Cancer Cell Proliferation, Apoptosis, Migration, Invasion and Aerobic Glycolysis by Targeting YES1</p>. OncoTargets and Therapy. Volume 13. 11289–11299. 30 indexed citations
12.
Li, Huibing, et al.. (2020). MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2. Human Cell. 33(3). 619–629. 13 indexed citations
13.
Wang, Xiaohui, et al.. (2020). <p>Ribosome Binding Protein 1 Correlates with Prognosis and Cell Proliferation in Bladder Cancer</p>. OncoTargets and Therapy. Volume 13. 6699–6707. 6 indexed citations
14.
Zhou, Bisheng, et al.. (2018). CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2. Cell Cycle. 17(23). 2644–2654. 72 indexed citations
16.
Wang, Che, Lili Tian, Song Li, et al.. (2013). Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism. PLoS ONE. 8(4). e60462–e60462. 62 indexed citations
17.
Wang, Che, Huibing Li, Song Li, Lili Tian, & Dejing Shang. (2011). Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis). Biochimie. 94(2). 434–441. 61 indexed citations
18.
Wang, Che, Song Li, Dejing Shang, et al.. (2011). Antihyperglycemic and neuroprotective effects of one novel Cu–Zn SOD mimetic. Bioorganic & Medicinal Chemistry Letters. 21(14). 4320–4324. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026